To strengthen collaboration in glaucoma research among leading institutions in Philadelphia.
Approach:
Key Findings:
Emphasis on neuroprotection, regeneration, and earlier intervention in glaucoma research.
Advancements in imaging biomarkers and quantitative analysis for tracking disease progression.
Emerging gene-based therapies and strategies for preserving ganglion cell viability.
Interpretation:
The retreat showcased the depth of glaucoma research in Philadelphia and the importance of collaborative efforts in accelerating discoveries and therapeutic development.
Limitations:
Focus on specific areas may overlook other important aspects of glaucoma research.
Potential for bias in collaborative discussions due to institutional affiliations.
Conclusion:
Future progress in glaucoma treatment may depend on coordinated networks that validate biomarkers and translate experimental therapies into practice.
